Here are relevant reports on : diabetes-care-devices-market
-
Efficacy Testing Market by Service Type (Antimicrobial/Preservative Efficacy Testing, Disinfectant Efficacy Testing), Application (Pharma, Cosmetics & Personal Care, Medical Devices, Consumer Products) and Region - Global Forecast to 2027
The global efficacy testing market growth is primed to transition from $315 million in 2022 to $423 million by 2027, showcasing a strong CAGR of 6.1%. Factors such as regulations for pharmaceutical and cosmetic products addressing the safety of the products are expected to drive the growth of the global market for efficacy testing in the coming years.
- Published: July 2022
- Price: $ 4950
- TOC Available:
-
Pain Management Devices Market by Type (Neurostimulation, Infusion Pump, Ablation), Application (Neuropathic, Musculoskeletal, Cancer pain), Mode of Purchase (Prescription, OTC), By End user (Hospital, Physiotherapy, Home care) - Global Forecast to 2029
The global pain management devices market, valued at US$3491.0 million in 2023, stood at US$3,768.6 million in 2024 and is projected to advance at a resilient CAGR of 9.1% from 2024 to 2029, culminating in a forecasted valuation of US$5,835.8 million by the end of the period. The increasing prevalence of chronic pain conditions, coupled with a growing number of surgical procedures, rising technological advancements, an expanding aging patient population, an established reimbursement framework promoting access to pain management devices, and emerging market opportunities are expected to drive market growth during the forecast period.
- Published: October 2024
- Price: $ 4950
- TOC Available:
-
Airway Management Devices Market by Type (Endotracheal tubes, Tracheostomy tube, Oropharyngeal, Nasopharyngeal, Laryngoscopes, Resuscitators), Application (Anesthesia, Emergency medicine), End User (Hospitals, Home care settings) - Global Forecast to 2028
The global airway management devices market, valued at US$1.8 billion in 2022, stood at US$1.9 billion in 2023 and is projected to advance at a resilient CAGR of 5.6% from 2023 to 2028, culminating in a forecasted valuation of US$2.4 billion by the end of the period. The growth in this market is attributed to the increasing demand for airway management devices in developing countries, the rise in surgical procedures, and the growing prevalence of chronic respiratory diseases such as asthma and COPD.
- Published: April 2023
- Price: $ 4950
- TOC Available:
-
Oxygen Therapy Equipment Market by Product (Oxygen Source (Concentrator, Cylinder), Delivery Devices), Portability (Stationary, Portable), Application (COPD, Asthma, Cystic Fibrosis, Pneumonia), End User (Hospital, Home Care) - Global Forecast to 2022
The oxygen therapy equipment market is expected to reach USD 4.01 Billion by 2022 from USD 2.65 Billion in 2017, at a CAGR of 8.7% from 2017 to 2022. Factors driving the growth of this market are the increasing prevalence of respiratory disorders, rapid growth in the geriatric population, prevalence of tobacco smoking, preference towards home-based oxygen therapy, and technological advancements to develop novel products delivering oxygen therapy.
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
Medical Foam Market by Form (Flexible, Rigid, Spray), Material (Polymers, Latex, Metals), Application (Bedding & Cushioning, Packaging, Devices & Components, Prosthetics & Wound Care, Swabs, Filters, Wipes) and Region - Global Forecast to 2028
The medical foam market is expected to grow from USD 33.0 billion in 2023 to USD 43.3 billion by 2028, at a CAGR of 5.6% during the forecast period. Some of the leading manufacturers of medical foam profiled in this report are The Dow Chemical Company (US), Sekisui Chemical Co., Ltd. (Japan), Huntsman Corporation (US), Trelleborg AB (Sweden), BASF SE (Germany), Recticel NV (Belgium), INOAC Corporation (Japan), UFP Technologies, Inc. (US), FXI Holdings, Inc. (US), Armacell International SA (Germany), Rogers Corporation (US), Freudenberg Group (Germany), and Molnlycke Health Care (Sweden).
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Acute Wound Care Market by Product (Dressings (Foam, Hydrocolloid, Film), Devices (NPWT, Electric Stimulation, Oxygen & Hyberbaric Oxygen, Pressure Relief)), Wound Type (Surgical, Burns), End User (Hospitals, Clinics), & Region - Global Forecast to 2027
The global acute wound care market size is projected to reach USD 10,457.8 million by 2027 from USD 8,452.4 million in 2022, at a CAGR of 4.3% during the forecast period. The market is driven by factors such as the growing number of surgical procedures, growing incidence of burn injuries, and growing geriatric patient pool. Emerging economies such as China and Japan are providing lucrative opportunities for the players operating in the acute wound care market.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Personal Care Ingredients Market by Ingredient Type (Emollients, Surfactants, Rheology Modifiers, Emulsifiers, Conditioning Polymers), Application (Skin Care, Hair Care, Oral Care, Makeup), and Region - Global Forecast to 2030
The personal care ingredients market size was USD 13.17 billion in 2024 and is projected to reach USD 17.00 billion by 2030, at a CAGR of 4.40%, between 2025 and 2030. The key market players profiled in the report include as BASF SE (Germany), Dow Inc. (US), Syensqo SA/NV (Belgium), Clariant AG (Switzerland), Ashland Inc. (US), ADEKA Corporation (Japan), The Lubrizol Corporation (US), Evonik Industries AG (Germany), Nouryon (Netherlands), and Croda International Plc (US).
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Natural Personal Care Ingredients Market by Type (Emollients, Surfactnats, Rheology Modifiers, Preservatives, Active Ingredients), Application (Skin Care, Hair Care, Make-up, Oral Care), and Region - Global Forecast to 2028
The natural personal care ingredients market is expected to grow from USD 5.3 billion in 2022 to USD 7.9 billion by 2028, at a CAGR of 8.3% during the forecast period. The key players profiled in the report include BASF SE (Germany), Croda International Plc (UK), Ashland Inc. (US), The Lubrizol Corporation (US), Evonik Industries AG (Germany), Dow Inc. (US), Symrise AG (Germany), and others.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Medical Device Reprocessing Market by Type (Reprocessed Medical Devices), Device Category (Critical- Devices, Semi-Critical Devices, Non-Critical Devices), Application (Cardiology, Gynecology, Gastroenterology, Anesthesia) - Global Forecast to 2027
The global medical device reprocessing market growth is primed to transition from USD 2.0 billion in 2022 to USD 3.9 billion by 2027, showcasing a strong CAGR of 13.7%. Growth in the market is mainly driven by the favorable regulatory standards for adoption of reprocessed medical devices by healthcare providers. On the other hand, the risk of infection from reprocessed medical devices may pose a threat to the market growth.
- Published: July 2022
- Price: $ 4950
- TOC Available:
-
Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Angioplasty Stent, Catheters (IVUS/OCT), Plaque Modification, Vascular Closure Devices, Balloon Inflation Devices, Hemodynamic Flow Alteration), End User - Global Forecast to 2031
The global peripheral vascular devices market, valued at USD 9.55 billion in 2025, stood at USD10.02 billion in 2026 and is projected to advance at a resilient CAGR of 5.7% from 2026 to 2031, culminating in a forecasted valuation of USD13.22 billion by the end of the period. The market for peripheral vascular devices is anticipated to grow due to several factors, including the rising incidence of peripheral artery disease and diabetes, an increasingly aging global population, and a preference for minimally invasive endovascular procedures that reduce hospital stays and recovery times.
- Published: February 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
